• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNF-α 启动子多态性与多发性骨髓瘤无关:一项荟萃分析。

Lack of association between TNF-α promoter polymorphisms and multiple myeloma: a meta-analysis.

机构信息

Department of Orthopeadics, Tianjin Hospital, Tianjin Medical University, Tianjin, China.

出版信息

Leuk Res. 2013 Jan;37(1):50-7. doi: 10.1016/j.leukres.2012.08.027. Epub 2012 Sep 20.

DOI:10.1016/j.leukres.2012.08.027
PMID:22999526
Abstract

Results of available literatures, which concerned the association between TNF-α promoter -238/-308 gene polymorphisms and multiple myeloma (MM), are of great controversy. A review was performed in studies reporting on the association between them. Odds ratios (ORs) with 95% confidence interval (CI) were used to evaluate the association. The pooled ORs indicated that there was no association between TNF-α -238/-308 polymorphisms and MM susceptibility in overall population. Sub-group analysis also confirmed that no evidence supported the relevance of TNF-α promoter -238/-308 gene polymorphisms with MM. Studies with large sample size and multi-ethnics may be needed to further explore the association between them.

摘要

现有文献研究结果表明,肿瘤坏死因子-α 启动子-238/-308 基因多态性与多发性骨髓瘤(MM)之间存在关联,但存在较大争议。本研究对相关文献进行了综述。采用比值比(OR)及其 95%置信区间(CI)来评估关联。汇总 OR 表明,TNF-α-238/-308 多态性与总体人群 MM 易感性之间无关联。亚组分析也证实,TNF-α 启动子-238/-308 基因多态性与 MM 无相关性。可能需要进行更大样本量和多民族的研究来进一步探讨它们之间的关系。

相似文献

1
Lack of association between TNF-α promoter polymorphisms and multiple myeloma: a meta-analysis.TNF-α 启动子多态性与多发性骨髓瘤无关:一项荟萃分析。
Leuk Res. 2013 Jan;37(1):50-7. doi: 10.1016/j.leukres.2012.08.027. Epub 2012 Sep 20.
2
Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis.肿瘤坏死因子-α启动子多态性与强直性脊柱炎的关联性缺失:一项荟萃分析
Rheumatology (Oxford). 2009 Nov;48(11):1359-62. doi: 10.1093/rheumatology/kep260. Epub 2009 Aug 31.
3
[Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma].多发性骨髓瘤中白细胞介素6和肿瘤坏死因子α基因多态性的分子遗传学分析
Mol Biol (Mosk). 2003 May-Jun;37(3):420-4.
4
Association of tumor necrosis factor-α gene promoter polymorphisms (-308G/A, -238G/A) with recurrent spontaneous abortion: a meta-analysis.肿瘤坏死因子-α基因启动子多态性(-308G/A、-238G/A)与复发性自然流产的相关性:荟萃分析。
Hum Immunol. 2012 May;73(5):574-9. doi: 10.1016/j.humimm.2012.01.008. Epub 2012 Feb 14.
5
Lack of association between TNF-α gene promoter polymorphisms and pancreatitis: a meta-analysis.TNF-α 基因启动子多态性与胰腺炎之间缺乏关联:一项荟萃分析。
Gene. 2012 Jul 25;503(2):229-34. doi: 10.1016/j.gene.2012.04.057. Epub 2012 Apr 28.
6
Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.肿瘤坏死因子-α基因多态性与非小细胞肺癌易感性及严重程度的关联
Lung Cancer. 2006 Apr;52(1):15-20. doi: 10.1016/j.lungcan.2005.11.011. Epub 2006 Feb 14.
7
[Effect of TNF-alpha gene polymorphism on outcome of thalidomide-based regimens for multiple myeloma].[肿瘤坏死因子-α基因多态性对沙利度胺方案治疗多发性骨髓瘤疗效的影响]
Zhonghua Xue Ye Xue Za Zhi. 2009 Oct;30(10):649-53.
8
Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.TNF-α 启动子多态性在沙利度胺联合地塞米松治疗多发性骨髓瘤中的作用及其对临床结局的影响。
Leuk Res. 2010 Nov;34(11):1453-8. doi: 10.1016/j.leukres.2010.01.011. Epub 2010 Jan 31.
9
Association of tumor necrosis factor-α gene promoter polymorphism at sites -308 and -238 with non-alcoholic fatty liver disease: a meta-analysis.肿瘤坏死因子-α基因启动子多态性与非酒精性脂肪性肝病的关系:一项荟萃分析。
J Gastroenterol Hepatol. 2012 Apr;27(4):670-6. doi: 10.1111/j.1440-1746.2011.06978.x.
10
TNF polymorphisms in patients with Behçet disease: a meta-analysis.白塞病患者 TNF 多态性的荟萃分析。
Arch Med Res. 2010 Feb;41(2):142-6. doi: 10.1016/j.arcmed.2010.02.002. Epub 2010 Mar 24.

引用本文的文献

1
Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab.达雷妥尤单抗治疗多发性骨髓瘤中炎症介质的疗效评估
J Oncol. 2022 Aug 27;2022:9350211. doi: 10.1155/2022/9350211. eCollection 2022.
2
Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells.阿替利珠单抗通过作用于 PERK/eIF2α/ATF4/CHOP 和 STAT3/NF-ΚB 轴诱导 MDA-MB-231 和 MDA-MB-468 乳腺癌细胞凋亡。
Mol Biol Rep. 2021 Jun;48(6):5233-5247. doi: 10.1007/s11033-021-06528-1. Epub 2021 Jul 9.
3
The Association of , and α Polymorphisms With the Risk and Outcome in Multiple Myeloma.
[具体基因名称]、[另一基因名称]和α多态性与多发性骨髓瘤的风险及预后的关联
Front Oncol. 2019 Oct 11;9:1056. doi: 10.3389/fonc.2019.01056. eCollection 2019.
4
A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma.AGS3 在多发性骨髓瘤中的作用。
Int J Hematol. 2014 Jan;99(1):57-68. doi: 10.1007/s12185-013-1484-8. Epub 2013 Dec 5.